Weiguang Zeng

This inventor holds 13 USPTO granted patents and 6 published patent applications and 9 EPO patents. Top assignees: Queensland Institute of Medical Research, Ena Respiratory Pty Ltd, Ena Therapeutics Pty Ltd. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weiguang Zeng. Retrieved from https://idiyas.com/inventor/weiguang-zeng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 6)

% Patents Active = 61.5

EPO Patents = 9 (Patent Applications = 2)

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 52(Granted Patents)

Location History:

Parkville, AU (2016)
Carlton, AU (2017)
Kensington, AU (2009 - 2023)
Melbourne, AU (2024)

Company Filing History:

4 out of 31

Queensland Institute of Medical Research

patents

3 out of 3

Ena Respiratory Pty Ltd

patents

2 out of 2

Ena Therapeutics Pty Ltd

The University of Melbourne

patents

6. 1 out of 2,130

Council of Scientific and Industrial Research

patents

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12569431 - IMMUNOSTIMULATORY METHOD (2026-03-10),

2. 12017979 - Molecules (2024-06-25),

3. 11786458 - Immunostimulatory method (2023-10-17),

4. 11351114 - Immunostimulatory method (2022-06-07),

5. 10406100 - Immunostimulatory method (2019-09-10),

6. 9889195 - Immunogenic composition and uses thereof (2018-02-13),

7. 9676819 - Immunostimulatory method (2017-06-13),

8. 9340622 - Synthetic immunogen useful for generating long lasting immunity and protection against pathogens (2016-05-17),

9. 9089508 - Method of transfection and compositions therefor (2015-07-28),

10. 8986700 - Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes (2015-03-24),

11. 8367067 - Immunogenic lipopeptides comprising T-helper and B-cell epitopes (2013-02-05),

12. 7833532 - Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopes (2010-11-16),

13. 7569225 - Immunogenic lipopeptides comprising T-helper and B-cell epitopes (2009-08-04),

Title: The Innovative Journey of Inventor Weiguang Zeng

Introduction: Weiguang Zeng, a talented inventor hailing from Kensington, Australia, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Zeng's latest patents include cutting-edge advancements in renewable energy technology, smart home devices, and artificial intelligence systems, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Weiguang Zeng has established himself as a pioneer in the tech industry, with a keen focus on sustainability and efficiency. His inventions have revolutionized various sectors, earning him recognition as a visionary inventor.

Collaborations: Zeng has collaborated with leading research institutions, universities, and tech companies worldwide to further develop and implement his inventions. His collaborative spirit and innovative mindset have led to the successful realization of groundbreaking technologies.

Conclusion: Weiguang Zeng's passion for innovation, coupled with his dedication to creating a sustainable future, has solidified his position as a prominent figure in the world of inventors. His relentless pursuit of technological advancement continues to inspire and shape the future of innovation.

Profile summary based on public USPTO records.